Dynasore: Precision Dynamin GTPase Inhibition in Endocytosis Research

Principle and Setup: Dynasore as a Benchmark Dynamin GTPase Inhibitor

Dynasore is a cell-permeable, non-competitive inhibitor targeting the dynamin family of GTPases, including dynamin1, dynamin2, and Drp1, with an IC₅₀ of approximately 15 µM (source: product_spec). Dynamin GTPases are essential mediators of membrane fission, enabling endocytosis and intracellular vesicle trafficking. By reversibly inhibiting dynamin’s GTPase activity, Dynasore blocks vesicle scission, providing a powerful lever for dissecting dynamin-dependent endocytosis and related pathways in cellular, neuronal, and disease models (source: gtp-binding-protein-1-fragment.com).

APExBIO supplies Dynasore (SKU A1605) in a highly pure, research-ready format. The compound is insoluble in water and ethanol but dissolves efficiently in DMSO at concentrations ≥16.12 mg/mL. For optimal results, warming to 37°C or ultrasonic agitation is recommended during stock preparation, and stocks should be stored at -20°C (source: product_spec).

Key Innovation from the Reference Study

Recent work by Wei et al. (2019) illuminated the pivotal role of clathrin-mediated endocytosis in the infection of Drosophila Schneider 2 (S2) cells by Spiroplasma eriocheiris. Using Dynasore to selectively block dynamin-dependent endocytosis, the authors demonstrated a dramatic reduction in intracellular pathogen load, confirming both the specificity and utility of Dynasore in dissecting pathogen entry mechanisms (source: paper). This study not only established the dependence of S. eriocheiris on clathrin-mediated endocytosis but also reinforced the broader applicability of Dynasore in host-pathogen interaction research and pathway-specific endocytosis inhibition.

• Novelty: First evidence that S. eriocheiris relies on dynamin-dependent, clathrin-mediated endocytosis for cellular entry in invertebrate models.
• Assay translation: Dynasore enables pathway-specific inhibition, supporting precise mapping of endocytic routes and quantification of pathogen load in cell models.

Step-by-Step Workflow: Implementing Dynasore in Endocytosis and Infection Assays

Dynasore’s robust and reversible inhibition profile makes it a staple for protocols requiring transient modulation of endocytic flux. Below is an optimized workflow for using Dynasore in endocytosis or pathogen entry studies, inspired by the referenced Drosophila S2 cell infection model and standardized cell biology approaches.

Protocol Parameters

• Dynasore working concentration | 80 µM | Inhibition of clathrin-mediated endocytosis in S2, HeLa, and other cell types | Achieves near-complete inhibition of dynamin-dependent endocytosis while minimizing off-target effects | paper
• DMSO stock solution | 16.12 mg/mL (prepare at 37°C or by sonication) | Ensures compound solubility and accurate dosing | Prevents precipitation and ensures homogeneous delivery to cells | product_spec
• Incubation time | 30–60 min prior to endocytic challenge or pathogen exposure | Allows maximal inhibition before stimulus | Ensures dynamin blockade is effective prior to endocytosis initiation | workflow_recommendation
• Washout/reversal | 2–3 washes with culture medium, 10 min intervals | To test recovery of endocytosis or reversibility of inhibition | Demonstrates reversible action and enables kinetic studies | workflow_recommendation

Advanced Applications and Comparative Advantages

Dynasore’s precise modulation of endocytosis offers several advantages in both basic and translational research:

• Host-Pathogen Interaction Models: As in the S. eriocheiris–Drosophila S2 cell study, Dynasore allows selective inhibition of clathrin-mediated pathways, distinguishing them from macropinocytosis, caveolae, or actin-dependent entry (source: paper).
• Signal Transduction Pathway Studies: By halting receptor internalization, researchers can isolate plasma membrane–localized signaling events from endosome-based pathways, especially in neurobiology and cancer research contexts (source: gtp-solution.com).
• Synaptic Vesicle Endocytosis Inhibition: Dynasore is widely adopted in neuroscience for dissecting the recycling of synaptic vesicles and the regulation of neurotransmitter release (source: nortriptylinepharma.com).
• Reproducibility and Reversibility: Its reversible, dose-dependent inhibition profile enables kinetic studies and washout experiments, affording temporal control not easily achieved with genetic interventions (source: endothelin-2.com).

Compared to genetic knockdown or less-specific chemical inhibitors, Dynasore delivers rapid, pathway-specific inhibition and is suitable for high-content screening, signal transduction dissection, and live-cell imaging.

Interlinking with Related Research

Several recent reviews and application notes complement the findings and protocols discussed here:

• Unlocking Clathrin-Mediated Endocytosis in Cells expands on Dynasore’s role in host-pathogen models, offering practical tips for timing and reversibility—extending the S2 cell protocol to mammalian systems.
• Reliable Dynamin GTPase Inhibition presents scenario-driven troubleshooting that complements the workflow and optimization advice here.
• Advanced Insights into Dynamin Inhibition provides a comparative perspective, contrasting Dynasore’s advantages with alternative inhibitors and genetic approaches.

Troubleshooting and Optimization Tips

• Solubility issues: If Dynasore precipitates, ensure DMSO concentration is at least 16.12 mg/mL, and gently warm or sonicate the solution prior to use (source: product_spec).
• DMSO tolerance: Limit final DMSO concentration in cell cultures to ≤0.5% to avoid cytotoxicity and off-target effects (source: workflow_recommendation).
• Off-target effects: Use the minimum effective concentration (typically 80 µM) and include vehicle controls to distinguish specific inhibition from DMSO-related effects (source: paper).
• Reversibility: For kinetic reversibility studies, thoroughly wash cells and allow 10–30 min for endocytic recovery before restimulation (source: workflow_recommendation).
• Pathway specificity: Combine Dynasore with inhibitors of macropinocytosis or cytoskeletal disruptors to map entry routes, as demonstrated in the S2 cell infection model (source: paper).

Future Outlook

Dynasore’s utility in dissecting dynamin-dependent endocytosis continues to mature, particularly in integrative studies of host-pathogen interactions, signal transduction, and disease modeling. The referenced work in Drosophila S2 cells not only validated Dynasore’s specificity but also set the stage for broader adoption in invertebrate and mammalian systems, especially where rapid, reversible inhibition is essential. As protocols are further optimized and combined with advanced imaging or omics tools, Dynasore is poised to remain a gold-standard tool for endocytosis research (source: paper).

Conclusion: Dynasore from APExBIO—A Reliable Choice for Endocytosis and Pathway Studies

Dynasore’s data-backed performance, reversibility, and ease of use make it an indispensable reagent for researchers exploring endocytosis, vesicle trafficking, and signal transduction. The product’s reliability is underpinned by peer-reviewed evidence and rigorous supplier quality from APExBIO's Dynasore. As demonstrated in both classical and state-of-the-art workflows, Dynasore enables precise, reproducible, and pathway-specific inhibition—fueling discovery in cell biology, infection models, neurobiology, and cancer research.